Daraxonrasib trial shrinks pancreatic tumors; undetectable in 1 in 12 patients
Published 1 d ago2 sourcesEvidence: Reported
Scientists report a breakthrough oral treatment for pancreatic cancer, with one researcher describing the trial results as the 'closest thing to a cure.' The claim is based on trial data, but specific efficacy figures, patient cohorts, and regulatory status remain undisclosed, so the magnitude of the effect is unverified. If confirmed, this would be a major advance against one of the deadliest cancers, though it is not yet a market-moving or policy-shifting event.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Published 1 d ago2 sourcesEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 3 d ago1 sourceEvidence: Reported
Published 1 d ago2 sourcesEvidence: Reported
Published 12 h ago1 sourceEvidence: Reported
Published 2 d ago2 sourcesEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported